Cytosorbents announces compliance with nasdaq minimum bid price requirement

Princeton, n.j., aug. 01, 2024 (globe newswire) -- cytosorbents corporation (nasdaq: ctso), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that it has regained compliance with the nasdaq stock market's minimum bid price requirement of $1.00 per share.
NDAQ Ratings Summary
NDAQ Quant Ranking